Kenyon Martin Jr. (Houston Rockets) with a block vs the Dallas Mavericks, 01/23/2021
Kenyon Martin Jr. (Houston Rockets) with a block vs the Dallas Mavericks, 01/23/2021
The TV star said he is now feeling better than ever.
In 2022, the world's leading trade fair for toys is launching an innovative business platform known as Spielwarenmesse Digital. In doing so, the organiser is responding to the needs of both visitors and exhibitors by combining the indispensable live event with a range of digital opportunities. The new feature will be introduced at the Spielwarenmesse after next, which is due to open its doors from 2 to 6 February 2022. Companies can already sign up from 1 March 2021. Much like the physical trade fair in Nuremberg, Spielwarenmesse Digital showcases the product and company presentations of market leaders and newcomers, whilst offering the best networking opportunities in the industry and a high-calibre seminar programme for suppliers as well as retailers and buyers.
The "Skin Rejuvenation Devices - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.
Bids, sales, stop-rates and prices are presented in the table below: ISINBid Mill. kr. (nominal)SaleStop-rate (per cent)Pro-rataPrice98 18189 DKT 01/06/21 II1,3601,360 -0.530 100 % 100.1356 98 18262 DKT 01/09/21 III460460 -0.520 100 %100.266598 18346 DKT 01/12/21 IV 1,6801,680-0.520100 %100.398898 18429 DKT 01/03/22 I 3,3803,380-0.520100 %100.5300Total6,8806,880 The sale will settle 1 March 2021.
U.S. Capitol Police were aware of the possibility of violence from armed extremists when the Capitol was attacked by supporters of former President Donald Trump, but quickly became overwhelmed by "insurrectionists", the acting police chief said. Intelligence collected ahead of the Jan. 6 assault on the Capitol suggested that the gathering would have the participation of armed "militia members, white supremacists, and other extremist groups," Yogananda Pittman said in a prepared testimony to be delivered Thursday before the House Appropriations Committee. Pittman was the assistant chief of police of the department's Protective and Intelligence Operations on Jan. 6 and said she was responsible for its Intelligence and Interagency Coordination Division (IICD).
Dublin, Feb. 25, 2021 (GLOBE NEWSWIRE) -- The "Cards & Payments Global Market Report 2021: COVID-19 Impact and Recovery to 2030" report has been added to ResearchAndMarkets.com's offering. Cards & Payments Global Market Report 2021: COVID-19 Impact and Recovery to 2030 provides the strategists, marketers and senior management with the critical information they need to assess the global cards & payments market as it emerges from the COVID-19 shut down. Major companies in the cards and payments market include American Express Company; Visa; Bank of America; PayPal and Mastercard.The global cards & payments market is expected to grow from $671.73 billion in 2020 to $729.9 billion in 2021 at a compound annual growth rate (CAGR) of 8.7%. The growth is mainly due to the companies rearranging their operations and recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The market is expected to reach $961.34 billion in 2025 at a CAGR of 7%.The cards and payments market consists of sales of cards and payments services by entities (organizations, sole traders and partnerships) that are engaged in storing, processing and transmitting payment card data. The cards and payments market is segmented into cards; and payments.Asia Pacific was the largest region in the global cards & payments market, accounting for 33% of the market in 2020. Western Europe was the second largest region accounting for 23% of the global cards & payments market. South America was the smallest region in the global cards & payments market.Cards and payments companies are investing in technologies and formulating guidelines to prevent card and payment frauds. In this regard, payment service providers and merchants have implemented various solutions including the Payment Card Industry Data Security Standard (PCI DSS) compliance, EMV technology, 3-D Secure services, tokenization, biometrics and end-to-end encryption. To combat the constantly evolving card fraud methods, the National Retail Federation (NRF) also updates its security guidelines continuously.Key Topics Covered: 1. Executive Summary2. Report Structure3. Cards & Payments Market Characteristics3.1. Market Definition3.2. Key Segmentations4. Cards & Payments Market Product Analysis4.1. Leading Products/ Services4.2. Key Features and Differentiators4.3. Development Products5. Cards & Payments Market Supply Chain5.1. Supply Chain5.2. Distribution5.3. End Customers6. Cards & Payments Market Customer Information6.1. Customer Preferences6.2. End Use Market Size and Growth7. Cards & Payments Market Trends And Strategies8. Impact Of COVID-19 On Cards & Payments9. Cards & Payments Market Size And Growth9.1. Market Size9.2. Historic Market Growth, Value ($ Billion)9.2.1. Drivers Of The Market9.2.2. Restraints On The Market9.3. Forecast Market Growth, Value ($ Billion)9.3.1. Drivers Of The Market9.3.2. Restraints On The Market10. Cards & Payments Market Regional Analysis10.1. Global Cards & Payments Market, 2020, By Region, Value ($ Billion)10.2. Global Cards & Payments Market, 2015-2020, 2020-2025F, 2030F, Historic And Forecast, By Region10.3. Global Cards & Payments Market, Growth And Market Share Comparison, By Region11. Cards & Payments Market Segmentation11.1. Global Cards & Payments Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion CardsPayments 11.2. Global Cards & Payments Market, Segmentation By Institution Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion Banking InstitutionsNon-Banking Institutions 12. Cards & Payments Market Segments12.1. Global Cards Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion) - Credit Card; Debit Card; Charge Card; Prepaid Card12.2. Global Payments Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion) -13. Cards & Payments Market Metrics13.1. Cards & Payments Market Size, Percentage Of GDP, 2015-2025, Global13.2. Per Capita Average Cards & Payments Market Expenditure, 2015-2025, Global Companies Mentioned American Express CompanyVisaBank of AmericaPayPalMastercard For more information about this report visit https://www.researchandmarkets.com/r/85hdif CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager firstname.lastname@example.org For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
Last summer, thousands of A-level students had their results downgraded from school estimates by a controversial algorithm.
Stay up-to-date with our weekly rundown on global travel news
Eleven Les Bleus players have now been infected in the past week as well as head coach Fabien Galthie
The "Co-Packaged Optics Markets 2021-2025" report has been added to ResearchAndMarkets.com's offering.
Dublin, Feb. 25, 2021 (GLOBE NEWSWIRE) -- The "Mail Order Pharmacy Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Drug Type; Product; Mode of Order, and Geography" report has been added to ResearchAndMarkets.com's offering. The market was valued at US$ 48,977 million in 2019 and is projected to reach US$ 166,384.85 million by 2027; it is expected to grow at a CAGR of 16.5% from 2020 to 2027. Based on drug type, the global mail order pharmacy market is segmented into prescription drugs and nonprescription drugs. The nonprescription drugs segment held a larger share of the market in 2019. This growth is ascribed to the increasing demand for over the counter (OTC) drugs such as cough and cold medications, analgesics, and gastrointestinal products. However, the prescription drugs segment is estimated to register a higher CAGR during the forecast period. This growth is attributed to increasing prevalence of chronic diseases, such as cancer, cardiovascular diseases and diabetes.In the North American region, the US is profoundly affected by the outbreak of the COVID-19 pandemic. The country has marked the highest number of positive cases. Across the nation, various healthcare research centers are working on the COVID-19 therapeutics. Additionally, during the initial phase of COVID-19 crisis, due to lockdown and supply chain disruptions the demand for mail order pharmacy was significantly increased owing to change in customer behaviors for purchasing prescription drugs.The growth of the mail order pharmacy market is attributed to the increasing incidences of chronic diseases and increasing adoption of mail order pharmacy in healthcare sector. However, the less adoption in low- and- middle income economies due to less penetration of e-commerce hinder the growth of this market. Canada Drugs Online, WellDyne, Walgreens co., eDrugstore.com, Zur Rose Group AG., CHI Health, Optumrx Inc., Express Scripts Holding Company, CVS Health, and PillPack are among the leading companies operating in the global mail order pharmacy market.Key Topics Covered: 1. Introduction1.1 Scope of the Study1.2 Report Guidance1.3 Market Segmentation2. Mail Order Pharmacy Market - Key Takeaways3. Research Methodology4. Mail Order Pharmacy Market - Market Landscape4.1 Overview4.2 PEST Analysis4.3 Expert Opinion5. Mail Order Pharmacy Market - Key Market Dynamics5.1 Market Drivers5.1.1 Increasing Incidences of Chronic Diseases5.1.2 Increasing Adoption of Mail Order Pharmacy in Healthcare Sector5.2 Market Restraint5.2.1 Less Adoption in Low-and-Middle Income Economies5.3 Market Opportunities5.3.1 Increasing Investment in Mail Order Pharmacy Start-Ups5.4 Future Trends5.4.1 Integration of Artificial Intelligence (AI) in Retail Pharmacies5.5 Impact Analysis of Drivers and Restraints6. Mail Order Pharmacy Market - Global Analysis6.1 Global Mail Order Pharmacy Market Revenue Forecast And Analysis6.2 Global Mail Order Pharmacy Market, By Geography - Forecast And Analysis6.3 Market Positioning of Key Players7. Mail Order Pharmacy Market Analysis - By Drug Type7.1 Overview7.2 Mail Order Pharmacy Market Revenue Share, by Drug Type (2019 and 2027)7.3 Prescription Drugs7.4 Non-Prescription Drugs8. Mail Order Pharmacy Market Analysis - By Product8.1 Overview8.2 Mail Order Pharmacy Market Revenue Share, by Product (2019 and 2027)8.3 Diabetes8.4 Asthma8.5 Blood Pressure8.6 Cardiovascular Medicines8.7 Cold and Flu8.8 Antacids8.9 Painkillers8.10 Dermal Care9. Mail Order Pharmacy Market Analysis - By Mode of Order9.1 Overview9.2 Mail Order Pharmacy Market Share, by Mode of Orders, 2019 and 2027, (%)9.3 Online Stores9.4 Pharmacy apps10. Mail Order Pharmacy Market - Geographic Analysis10.1 North America: Mail Order Pharmacy Market10.1.1 Overview11. Impact of COVID-19 Pandemic on Global Mail Order Pharmacy Market12. Industry Landscape12.1 Overview12.2 Growth Strategies Done by the Companies in the Market, (%)12.3 Organic Developments12.3.1 Overview12.4 Inorganic Developments12.4.1 Overview13. Company Profiles Canada Drugs OnlineWellDyneWalgreens co.eDrugstore.comZur Rose Group AGCHI HealthOptumrx Inc.Express Scripts Holding CompanyCVS HealthPillPack For more information about this report visit https://www.researchandmarkets.com/r/1b4ame CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager email@example.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
The star said he identified with the lead character in Mank and his own film The Way Back
Facebook said deadly violence in Myanmar had brought about the need for the ban on the military.
Buccaneers wide receiver Chris Godwin says the arrival of Tom Brady changed the team’s entire outlook in 2020. Godwin says Brady turned the Buccaneers into a team so confident that no one in the locker room ever doubted they were going to end up winning the Super Bowl. “I think the biggest thing that he [more]
Gavin Williamson to detail exam grade plans in parliament later on Thursday
As oil companies go out of business, they are leaving a legacy of abandoned wells that leak huge amounts of greenhouse gases into the atmosphere A pumpjack operates above an oilwell in the Bakken Formation outside Williston, North Dakota. Photograph: Daniel Acker/Getty Images Jill Morrison has seen how the bust of oil and gas production can permanently scar a landscape. Near her land in north-east Wyoming’s Powder River Basin, where drilling started in 1889, more than 2,000 abandoned wells are seeping brine into the groundwater and leaking potent greenhouse gasses. The problem is getting worse. As the oil and gas industry contracts owing to the pandemic, low prices and the rise of renewables, more than 50 major companies have gone bankrupt in the last year. Joe Biden’s recent order to pause drilling on federal land could drive that number higher. Morrison, a rancher and the head of the Powder River Basin resource council, said the crash was exacerbating the abandonment issue. “They drill baby drilled themselves right out of business,” Morrison said. “We’re seeing something we’ve never seen before in the oil and gas industry, in terms of the downturn, and there’s going to be a billion-dollar mess to clean up.” Unplugged wells, either orphaned well, which have no liable party, usually due to bankruptcy, or idle, abandoned ones, where the company has walked away, but could still be liable, cause rampant methane emissions – up to 8% of US total according to a 2014 analysis. They also leak brine, oil and fracking fluid into the groundwater, and carcinogenic gases, like benzine, into the air, and as their numbers increase the impacts grow. “Methane is a strong greenhouse gas, it’s a precursor for ozone, and harmful for human health,” said Mary Kang, a McGill civil engineering professor who conducted the study. “Even just a few wells can be responsible for big emissions, and there are all the other associated risks, and impacts to wildlife and ecosystems.” The impacts aren’t just here in the rangy fields of Wyoming. There are unremediated wells in Los Angeles neighborhoods and Pennsylvania farms. There could be as many as 3.2m abandoned wells in the US, according to a 2018 EPA report, but this is probably an undercount because both federal and state programs for regulating and monitoring non-producing wells are incomplete. There are an estimated 2,500 of them in the Powder River Basin alone. So many have been left uncapped because the regulations and bonding requirements, the money that companies pay ahead of time as insurance, for those wells are so minimal that it’s nearly impossible to hold drillers responsible or to pay for cleanup. Some companies simply walk away from wells, meaning they are still liable; when firms go out of business, they are not. The penalties for not cleaning up a well are minimal when there’s nothing but a small bond holding a company responsible. “How do you convince operators to comply when there’s no carrot and no stick?” said Frank Rusco, a director in the US Government Accountability Office’s natural resources and environment team. That means the profits for drilling go to individual companies while the damages, both environmental and financial, are largely borne by the local community and by state and federal taxpayers. “Unplugged wells devalue property, they’re a mess to work around, it can lead to groundwater pollution, and no one is really tracking it,” Morrison said. The thinktank Carbon Tracker, reports it could cost $280bn to reclaim wells, and public bonding data indicates that states have less than 1% of that money in secure bonds. Cleanup for an individual well can cost anywhere from $20,000 to $1m. It involves filling it with clay or concrete, covering the surface, replacing topsoil, and removing any pipes or waste like fracking fluid. Wyoming is shaking the stick harder than other places. In 2014, slumping prices set off a wave of bankruptcies and places like the Powder River Basin were hit hard by abandonment. In response, the Wyoming oil and gas commission upped their bonding fees, but there is still a big gap in funding. Wyoming has 64,000 orphaned unplugged wells, which would cost an estimated $10bn to remediate, according to an October report from the Carbon Tracker Initiative. Even with the increased bonding requirements, as of the most recent tally the state had about $225m in bonds. The Center for American Progress recently published a plan for a $2bn orphan well cleanup fund, which would both address the pollution and support 14,000 to 24,000 jobs in energy-producing states like Wyoming. And in September, Senator Michael Bennett of Colorado introduced a bill that included those recommendations to create a federal cleanup fund, and increase minimum bonds. “I think this is a two-step solution, first would be creating a cleanup fund to address the giant backlog of orphan wells that are scattered across the nation,” said report author Kate Kelly, public lands director at the center. “Then, the heart of the problem is that we have inadequate bonding requirements in places that allow oil and gas companies to walk away and leave taxpayers holding the bag.”
25, 2021 /CNW/ -- A report from Science and Technology Daily:Compared with the spring festivals before the COVID-19 pandemic, the celebration in this year is quite different. Many Chinese people chose not to go back to hometown as people are encouraged to stay where they are and celebrate the Spring Festival, so did a group of foreigners who work in China.
Dublin, Feb. 25, 2021 (GLOBE NEWSWIRE) -- The "Genomic Cancer Panel and Profiling Markets by Cancer and Germline/Somatic Type with Screening Potential Market Size, Customized Forecasting/Analysis, and Executive and Consultant Guides 2021-2025" report has been added to ResearchAndMarkets.com's offering. The report includes detailed breakouts for 18 Countries and 4 Regions. A detailed breakout for any country in the world is available to purchasers of the report.This report provides data that analysts and planners can use. Hundreds of pages of information including a complete list of Current 2020 United States Medicare Fee Payment Schedules to help understand test pricing in detail. Forecast demand for new testing regimes or technologies. Make research investment decisions. Existing laboratories and hospitals can use the information directly to forecast and plan for clinical facilities growth. Cancer Gene Panels and Genomic Profiling are quickly changing the diagnosis and treatment of cancers. The market is moving out of a specialized niche and going mainstream as Oncologists begin routinely using information on the hundreds of genes related to cancer. The market is exploding as physicians use all the information they can get in the battle against cancer. And there is a lot of information to be had. But the COVID-19 Pandemic has impacted the market. Find out how in this thorough report. Comprehensive panels, genomic profiling, high-risk breast cancer panels. Learn all about how players are jockeying for position in a market that is being created from scratch. And some players are already taking the lead. It is a dynamic market situation with enormous opportunity where the right diagnostic with the right support can command premium pricing. And the science is developing at the same time creating new opportunities with regularity. And the cost of sequencing continues to fall. Key Topics Covered: Cancer Panel Market - Strategic Situation Analysis & COVID Update Guide for Executives, Marketing, Sales and Business Development StaffGuide for Management Consultants and Investment Advisors 1. Introduction and Market Definition 1.1 What are Cancer Gene Panels and Profiling? 1.2 The Sequencing Revolution 1.3 Market Definition 1.3.1 Revenue Market Size1.4 Methodology 1.4.1 Authors 1.4.2 Sources 1.5 A Spending Perspective on Clinical Laboratory Testing 1.5.1 An Historical Look at Clinical Testing 2. Market Overview 2.1 Players in a Dynamic Market 2.1.1 Academic Research Lab 2.1.2 Diagnostic Test Developer2.1.3 Instrumentation Supplier 2.1.4 Distributor and Reagent Supplier 2.1.5 Independent Testing Lab2.1.6 Public National/regional lab 2.1.7 Hospital lab 2.1.8 Physician Office Labs 2.1.9 Audit Body 2.1.10 Certification Body2.2 Oncogenomics2.2.1 Carcinogenesis2.2.2 Chromosomes, Genes and Epigenetics 220.127.116.11 Chromosomes 18.104.22.168 Genes 22.214.171.124 Epigenetics 2.2.3 Cancer Genes 2.2.4 Germline vs Somatic 2.2.5 Gene Panels, Single Gene Assays and Multiplexing 2.2.6 Genomic Profiling 2.2.7 The Comprehensive Assay 2.2.8 Changing Clinical Role 2.2.9 The Cancer Screening Market Opportunity2.3 Cancer Management vs. Diagnosis 2.3.1 The Role of Risk Assessment 2.3.2 Diagnosis 2.3.3 Managing 2.3.4 Monitoring 2.4 Phases of Adoption - Looking into The Future 2.5 Structure of Industry Plays a Part 2.5.1 Hospital Testing Share 2.5.2 Economies of Scale126.96.36.199 Hospital vs. Central Lab 2.5.3 Physician Office Lab's 2.5.4 Physician's and POCT 3. Market Trends3.1 Factors Driving Growth3.1.1 Level of Care 3.1.2 Companion Dx 3.1.3 Immuno-oncology 3.1.4 Liability3.1.5 Aging Population3.2 Factors Limiting Growth3.2.1 State of knowledge3.2.2 Genetic Blizzard. 3.2.3 Protocol Resistance3.2.4 Regulation and coverage 3.3 Instrumentation and Automation 3.3.1 Instruments Key to Market Share 3.3.2 Bioinformatics Plays a Role 3.4 Diagnostic Technology Development3.4.1 Next Generation Sequencing Fuels a Revolution 3.4.2 Single Cell Genomics Changes the Picture 3.4.3 Pharmacogenomics Blurs Diagnosis and Treatment3.4.4 CGES Testing, A Brave New World 3.4.5 Biochips/Giant magnetoresistance based assay 4. Cancer Panels & Profiles Recent Developments 4.1 Recent Developments - Importance and How to Use This Section 4.1.1 Importance of These Developments 4.1.2 How to Use This Section Biocartis Collaborating With GeneproDx, Endpoint Health on Tests for Idylla PlatformWales to Routinely Screen Cancer Patients With Yourgene Elucigene TestMetastatic Cancer Markers Identified in Clinical WGS StudyStitch Bio Bets on CRISPR TechBayer, LifeLabs Launch Free NTRK Genetic Testing ProgramFoundation Medicine Liquid Biopsy Gets FDA Approval for Multiple Companion DxProgress, Challenges in Liquid Biopsy ReimbursementIsraeli Startup Curesponse Raises $6MInvitae, ArcherDX Merge to Advance Precision Oncology OfferingsMD Anderson Precision Oncology Decision Support to Use Philips' Informatics SolutionNeoGenomics, Lilly Oncology Partner for Thyroid Cancer Testing ProgramGermline Results Guides Precision Therapy in Advanced CancerFDA Clears Cancer Genomic Profiling Kit From Personal Genome DiagnosticsArcherDX, Premier Collaborate to Evaluate Genomic Sequencing Assay for CancersLabs Reporting Cancer Risk Mutations from Tumor TestingUsers Begin Integrating Genomics Data for Clinical Decision SupportFujitsu Improves Efficiency in Cancer Genomic MedicineThermo Fisher's automated sequencer to offer same-day, pan-cancer test resultsUniversal Genetic Testing for All Breast Cancer PatientsExact Sciences buys Genomic HealthMulti-Gene Liquid Biopsy Breast Cancer PanelThrive to Develop Earlier Detection of Multiple Cancer TypesNew Gene Panel Identifies High Risk Prostate CancerGuardant Health Liquid Biopsy Test to be Covered by EviCoreBiocept Partnership Offering for Liquid Biopsy Adds Several Key ServicesNatera Commercializes Tumor Whole Exome Sequencing from PlasmaInivata Completes 39.8M Series B Funding RoundBio-Rad Clinical ddPCR Test, Diagnostic System Get FDA ClearanceCellMax, Medigen Biotech Partner in Colorectal Cancer Clinical TrialsBiodesix Acquires Integrated DiagnosticsPredicine, Kintor Pharmaceuticals Partner on Clinical Trials, CDx 5. Profiles of Key Players Abbott DiagnosticsAccuraGen IncAcuamark DiagnosticsAdmera Health, LLCAgena Bioscience, IncAgilentAlmac DiagnosticsAmoy Diagnostics Co., Ltd.Anchor DxANGLE plcApoCell, Inc.ArcherDx, IncAsuragenAVIVA BiosciencesBaylor Miraca Genetics LaboratoriesBeckman Coulter, Inc.Becton, Dickinson and CompanyBGI Genomics Co. LtdBioarray GeneticsBiocartisBiocept, IncBiodesix IncBioFluidicabioMerieux DiagnosticsBioneer CorporationBio-Rad Laboratories, IncBio-TechneBioviewBlueprint GeneticsBolidicsBoreal GenomicsCaris Molecular DiagnosticsCellMax LifeCepheid (now Danaher)Chronix BiomedicalCirculogeneClinical GenomicsCynvenioCytolumina Technologies CorpCytoTrackDatar Cancer Genetics LimitedDiagenode DiagnosticsDiagnologix LLCEnzo Life Sciences, IncEpic SciencesEpigenomics AGEurofins ScientificExosome DiagnosticsExosome SciencesFluidigm CorpFluxion BiosciencesFoundation MedicineFreenomeFulgent GeneticsGeneFirst Ltd.Genetron Health (Beijing) Co., LtdGenomic HealthGILUPI NanomedizinGrail, Inc.Guardant HealthHansaBiomedHeiScreenHelomicsHorizon Discovery 224 iCellateIlluminaIncell DxInivataInvitae CorporationIntegrated DiagnosticsJanssen DiagnosticsLoxo OncologyMDNA Life SCIENCES, IncMDx HealthMenarini Silicon BiosystemsMillipore SigmaMiltenyi BiotecmiR ScientificMolecular MDMyriad Genetics/Myriad RBMNantHealth, Inc.NateraNeoGenomicsNew OncologyNovogene Bioinformatics Technology Co., Ltd.OncocyteOncoDNAOxford Nanopore TechnologiesPerkin ElmerPersonal Genome DiagnosticsPrecisionMedPromegaQiagen GmbhQuidelRarecells SASRareCyteResolution Biosciences, IncRoche Molecular DiagnosticsScreencellSiemens Healthineerssimfo GmbHSinglera Genomics IncSRI InternationalSysmex InosticsTempus Labs, IncThermo Fisher Scientific Inc.Thrive Earlier DetectionTrovageneVolition 6. The Global Market for Cancer Gene Panels and Profiles 6.1 Global Market Overview by Country6.2 Global Market by Cancer Type - Overview 6.3 Global Market Germline & Somatic - Overview 7. Global Cancer Gene Panels & Profiles Markets - By Type of Cancer 7.1 Comprehensive Panels & Profiles 7.2 Breast Cancer Gene Testing 7.3 Colorectal Cancer Gene Testing7.4 Gynecological Cancer Gene Testing 7.5 Blood Cancer Gene Testing 7.6 Prostate Cancer Gene Testing 7.7 Lung Cancer Gene Testing7.8 Other Cancer Gene Testing 8. Global Cancer Gene Testing Markets - Germline and Somatic 8.1 Global Market Somatic 8.2 Global Market Germline 9. Potential Market Opportunity Sizes 9.1 Potential Cancer Screening by Country: Lung, Breast & Colorectal 9.2 Potential Cancer Screening by Country: Prostate, Other Cancer & All Cancer 9.3 Potential Market Size - Cancer Diagnosis 9.4 Potential Market Size - Therapy Selection Appendices United States Medicare System: January 2020 Clinical Laboratory Fees ScheduleFDA Approved Human Genetic TestsPharmacogenomic Biomarkers in Drug Labeling For more information about this report visit https://www.researchandmarkets.com/r/wimp8l CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager firstname.lastname@example.org For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
European shares rose on Thursday, led by sectors expected to benefit from a broader economic recovery, as the U.S. Federal Reserve signalled it would maintain a loose monetary policy, while Standard Chartered fell as its profit slumped. U.S. Federal Reserve Chair Jerome Powell on Wednesday calmed fears that higher inflation would also lead to a tapering of monetary stimulus, saying the central bank would not change policy until the economy was clearly improving.
The dollar index fell to its lowest since early January on Thursday and dropped to three-year lows against the Australian and Canadian dollars, after dovish signals from the U.S. Federal Reserve boosted the reflation trade in currency markets. Easy financial conditions, the promise of fiscal stimulus and accelerating COVID-19 vaccine rollouts have driven money into what's known as the reflation trade, referring to bets on an upswing in economic activity and prices.